Therapeutic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514317, 514318, 514319, 514321, 514328, 514326, A61K 31445

Patent

active

051927721

ABSTRACT:
Compounds are described which are useful for lowering the activity of .alpha..sub.2 -PI, for the treatment of myocardial infarctions and cerebral infarctions, as urokinase secretion accelerators, as antithrombotic agents and to accelerate the fibrinolysis accelerating effect.

REFERENCES:
patent: 4182767 (1980-01-01), Murai et al.
patent: 4260622 (1981-04-01), Junge et al.
patent: 4312872 (1982-01-01), Junge et al.
patent: 4348402 (1982-09-01), Kinast et al.
patent: 4533688 (1985-08-01), Matsumura et al.
patent: 4639436 (1987-01-01), Junge et al.
Blomback et al, Plasma Proteins, 1976, pp. 288-308.
Aoki and Harpel, Seminars in Thrombosis and Hemostasis--vol. 10, No. 1, 1984.
Dictionary of Organic Compounds, 5th Edition, 2nd Supplement. Chapman & Hall, publication 1984.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-211727

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.